Japan Small Cap Growth: Pharma Foods - Hair Growth = Stock Growth
Pharma Foods has enjoyed 45% compound annual sales growth over the past five years and this year growth is expected to exceed 160%. Key driver is...
416 Views
JPX Nikkei 400 Index Rebalance: Better Late Than Never (32 Adds; 27 Deletes)
There are 32 inclusions and 27 exclusions from the JPX Nikkei 400. The changes will be effective after the close of trading on 27 November and the...
595 Views
(Mostly) Asia M&A: November 2019 Roundup
For the month of November, 21 new deals were discussed on Smartkarma with an overall announced deal size of ~US$75bn, helped in large part by...
777 Views
MitChem Deal for MitTanabePharma - Opportunistic But Likely Not To Cause Too Much Upset
After the close today, Mitsubishi Chemical (4188 JP) ("MCH") announced a Tender Offer to buy in the minorities of Mitsubishi Tanabe Pharma (4508...
552 Views
Mitsubishi Tanabe 1H FY18 (YE Mar'19) Results - First Glance
Key highlights Domestic pharma, contributing ~70% of total sales and one of the biggest victims of the ongoing pricing reforms in Japan, declined...
396 Views